Canada markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3600-0.0066 (-1.80%)
At close: 04:00PM EDT
0.3575 -0.00 (-0.69%)
After hours: 06:01PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Aridis Pharmaceuticals Announces $2.28 Million Registered Direct Offering of Common Stock

    Los Gatos, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 6,000,000 shares of the Company’s common stock at a purchase price of $0.38 per share in a registered direct offering. The closing of the offering is expected to occur on or about March 16, 2023, subject to the satisfaction of customary closing conditions. H.C. W

  • GlobeNewswire

    Aridis Meets Primary and Secondary Endpoints in Phase 2a Study of AR-501 in Cystic Fibrosis Patients

    The study achieved high uptake of AR-501 in the respiratory tract at levels that were more than 50-fold higher than required for inhibition of the target bacteria P. aeruginosa LOS GATOS, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced preliminary top-line results from the randomized, double blinded, placebo-controlled Phase 2a study of AR-501, which evaluated the safety and pharmacokinetics of three ascending doses of AR-501 administered as


    Interviews with Rail Vision, Aridis Pharmaceuticals, and Digital Ally to Air on Bloomberg U.S. on the RedChip Money Report(R)

    RedChip Companies will air new interviews with Rail Vision Ltd. (Nasdaq:RVSN), Aridis Pharmaceuticals, Inc. (Nasdaq:ARDS), and Digital Ally, Inc. (NASDAQ:DGLY) on The RedChip Money Report® on Bloomberg TV, this Saturday, February 18, at 7 p.m. Eastern Time (ET).